KCT0002933进行中(未招募)未知
Determination of the minimum effective concentration (MEC90) of dexmedetomidine for prolonged analgesia in patients undergoing interscalene brachial plexus block
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 69(Year)(—)
- 性别
- All
入选标准
- •Adult (>20 years old or =20, <70 years old)
- •patients with written informed consent
- •American society of anesthesiologist physical status I-III: Previous healthy (I), controlled systemic disease (II), uncontrolled systemic disease (III)
排除标准
- •American society of anesthesiologist physical status higher than IV
- •Child or old age
- •Sensory or motor deficit
- •Allergy to local anesthetic
- •Allergy to dexmedetomidine
- •Local infection at the site of interscalene brachial plexus block or systemic infection
- •Hepatic, cardiac, or renal disease
- •Coagulopathy (Prolonged INR>1.5)
- •Patient refusal
研究者
相似试验
招募中
不适用
Analysis of the effective dose for analgesia in knee surgery with saphenous nerve block by ultrasoundIndividuals with knee meniscopathyA02.835.583.475RBR-5jszxwniversidade Federal de São Paulo
进行中(未招募)
1 期
Détermination de la Concentration Minimale Efficace pour 90% de Ropivacaïne (MEC90) des blocs du plexus brachial au creux axillaire, avec et sans ajout de Dexamethasone intraveineusepatient bénéficiant d’un bloc du plexus brachial au creux axillaireEUCTR2018-002482-18-FRCHU de Besancon110
已完成
不适用
Comparison of minimum effective concentration of mepivacaine for axillary block in patients with/ without diabetic neuropathyEndocrine, nutritional and metabolic diseasesKCT0005715Inha University Hospital44
已完成
3 期
Minimal Effective Concentration (EC90) of RopivacaineAnesthesia, ConductionRopivacaineDexamethasoneAxillary Brachial Plexus BlockNCT03688269Centre Hospitalier Universitaire de Besancon146
已完成
4 期
Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee SurgeryKnee SurgeryPostoperative PainNCT02124005Ed Carlos Rey Moura45
